Intended for healthcare professionals

Search all rapid responses

All rapid responses

Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.

Re: Helen Salisbury: Should I persuade patients to have mammograms? Helen Salisbury. 365:doi 10.1136/bmj.l1409

Back in 2012, despite increasing evidence of breast screening harms and lack of benefit, GPs were being paid to encourage women to participate in the programme as part of 'local enhanced services payments' if a health authority deemed recruitment was getting too low.1
Such payments were not ethical then; in light of today's knowledge, are they not destined to invite litigation?

1 Blennerhassett M. Breast cancer screening: an ethical dilemma, or an opportunity for openness? Quality in Primary Care 2013; 21:39-42

Competing interests: No competing interests

05 April 2019
Mitzi A J Blennerhassett
medical writer/author, bmj patient reviewer
N/A
N/A
Slingsby, York, North Yorkshire.
Re: Clare Gerada: Mandatory training needs a fundamental review Clare Gerada. 365:doi 10.1136/bmj.l1406

How wonderful that at last after more than 40 years a Senior Colleague has recognised that as a profession we lack knowledge, skill and experience in the process of "education". On-line, solitary reading and multiple choice questions may lead to satisfying the requirements of revalidation but as Clare reminds us "it is conversation within our peer groups that leads us to the exploration of the significant uncertainties that is at the heart of everything we do as doctors".

There is a book on my shelf at home titled "Over Schooled but Under Educated". It makes it clear that much of what passes for "education" in the UK is in fact just "schooling" and not "education" at all -- i.e. it does not lead young minds to begin to love learning nor does it help students to start out on a journey of discovery to find the intellectual passions that will lead to a rich and happy life. Similarly what now passes for CPD sessions in General Practice is too often a lonely soul destroying misuse of time, money and energy. This approach to CPD and adult education in medicine and other professions seems to me to be the outcome of our collective failure to value the work of colleagues who really do understand and value education in its truest sense. Our modern world and our medical profession urgently needs to listen to real educationalists like Lewis Mumford.

About our modern world Lewis Mumford writes: "The most deadly criticism one could make of modern civilization is that apart from its man-made crises and catastrophes, it is not humanly interesting...In the end, such a civilization can produce only a mass man: incapable of choice, incapable of spontaneous, self-directed activities: at best patient, docile, disciplined to monotonous work to an almost pathetic degree, but increasingly irresponsible as his choices become fewer and fewer".

Being a GP is all about choices - choices about where to work and how to practise but just as importantly it is about helping patients and carers to see and understand the choices that they can make when faced with ill health, disease, difficult circumstances and maybe life limiting conditions. To be a doctor able to help patients and carers to make decisions and choices means that as a profession we must be the people that can facilitate the education and learning of our patients. Clearly if we are not ourselves people that love learning and people that fully understand that learning requires the right environment and motivation then we will not be able to help our patients to learn and make good choices themselves when faced with various treatment options.

Back in the late 1970s Dr John Macdonald at The Dept. of Education,University of Bristol, stated in Occasional Paper No 64, RCGP, that "alongside every GP Practice" there needs to be "a huge and sustained educational programme if patients are to be fully involved in their treatment and care". Maybe, just maybe, the contribution today from Clare Gerada might just possibly lead to a proper consideration of this neglected but very important aspect of our work as GPs.

Competing interests: No competing interests

05 April 2019
Malcolm S Rigler
Retired GP and Project Volunteer @ The Patients Association
The Patients Association and Member of CILIP
Orcop, Herefordshire
Re: Clare Gerada: Mandatory training needs a fundamental review Clare Gerada. 365:doi 10.1136/bmj.l1406

This is a very important point albeit presented in rather a mixed way. In fact there are several points. First mandatory training: essentially the course provided in my former Trust was a mixture of site related and professionally indicated subjects. An annual repetition of the same material was required. On reflection a generic course about site related issues like fire drill, security, etc, could have been provided for all staff and site users like voluntary workers. Separate courses from the relevant employees like food safety for nurses, caterers and others handling food or transfusion and pharmacy courses for medics and nurses would have been more logical.

Concerning revalidation, the whole system needs to be revisited and again could be better provided on a rolling programme of level 1 level 2 type generic courses involving skills like resuscitation, etc, while each specialty could have quinquennial exams based on testing knowledge delivered over the preceding five years. Currently revalidation is more of a test of compliance rather than competence.

Competing interests: No competing interests

05 April 2019
Evan A Bayton
Retired A&E Consultant
None. I am registered without a current licence to practice.
Warrington
Re: How can the NHS offer fulfilling, lifelong careers? Abi Rimmer. 364:doi 10.1136/bmj.l1100

The NHS could offer more fulfilling lifelong careers by taking more of an interest in the daily lives of those who work for it. Understanding a job plan is insufficient to understand the stresses and strains of work on the front line. Gone are the days of endless hours on-call, but the daily challenges of increasingly early starts to catch up with the accumulation of work, trying to avoid living off the hospital vending machines, fighting for a parking space or even receiving a ticket for parking at your place of work - as well as constantly rotating to new trusts with ever varying computer systems, protocols and passwords - distract and discourage and can slowly grind a workforce down.

To keep the plates of patient care spinning throughout the day is a never-ending and often amazing stage show played to an audience of none: everyone is just too busy to notice. The performance relies on ad-libs, leeway and workarounds. Understanding that ad-libs are necessary, understanding the need for leeway and understanding the nature of the workarounds is vital to an understanding of how the system and the people in that system really work. All of these things however are usually unseen, ignored or misinterpreted as being due to lack of professionalism, lack of commitment, lack of cooperation, lack of motivation, lack of intelligence or just plain laziness.

Currently the gulf is a very wide one - and unlikely to be addressable over a cup of tea - or by one.

Competing interests: No competing interests

05 April 2019
Emma Cannon
ACCS CT2
Mark Davies, consultant in anaesthesia & perioperative medicine
Royal Liverpool & Broadgreen University Hospitals NHS Trust
Liverpool L7 8XP
Re: Social prescribing Chris Drinkwater, Josephine Wildman, Suzanne Moffatt. 364:doi 10.1136/bmj.l1285

‘Social prescribing’ benefits both patients and society. Some prescribing however, whilst benefiting the patient might actually be viewed as being ‘anti-social’. We anaesthetists have recently become aware that our ultra-stable and ‘ultra-clean’ volatile anaesthetic desflurane is in fact far more environmentally damaging than other similar agents. The slightly faster wake-up profile comes at a pollution cost to the planet equivalent to burning buckets rather than bottles full of petrol. An invisible but real inferno in the operating theatre.

And our more liberal use of strong opioids to manage postoperative pain following early discharge from hospital. Often effective in the short-term and well-meaning undoubtedly, but perhaps one of the factors responsible for promoting long-term addiction, misuse and social misery.

Just as we need to think about ‘social prescribing’ we should also consider the possible ‘anti-social’ consequences of the medicines we use. We need not only to care for our patients, but also to look after their children and grandchildren.

Competing interests: No competing interests

05 April 2019
Sarah Hagyard
Junior Fellow in anaesthesia
Mark Davies, consultant in anaesthesia & perioperative medicine
Royal Liverpool & Broadgreen University Hospitals NHS Trust
Liverpool L7 8XP
Re: Helen Salisbury: Should I persuade patients to have mammograms? Helen Salisbury. 365:doi 10.1136/bmj.l1409

We would like to clarify that Cancer Research UK does not incentivise GPs with payments for improving screening uptake as could be inferred from the article, but that these payments are offered by CCGs. We believe that increasing uptake should not come at the expense of informed choice but through removing barriers to screening, so that individuals who want to attend are able to.

Cancer Research UK agrees that doctors should not be persuading patients to go for breast screening. But for all screening programmes, GPs should raise awareness of screening, give patients the information they need to make an informed decision and be available to answer any questions or concerns patients might have.

Competing interests: No competing interests

05 April 2019
Julie Sharp
Head of Health and Patient Information at Cancer Research UK
Cancer Research UK
The Angel Building, 407 St John St, London, EC1V 4AD
Re: NHS prescribed record number of antidepressants last year Gareth Iacobucci. 364:doi 10.1136/bmj.l1508

The prescription of antidepressants cannot simply be accumulated on a yearly basis. They are actually prescribed with considerable seasonal variation (Lansdall-Welfare, Lightman and Cristianini: The British Journal of Psychiatry (2019) Page 1 of 4. doi: 10.1192/bjp.2019.40). It would be helpful to assess the times of year when the increase in antidepressant treatment takes place before conclusions are made on the reasons for these changes.

Competing interests: No competing interests

05 April 2019
Stafford Lightman
Neuroscientist
University of Bristol
Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY
Re: QOF now accounts for less than 10% of GP practice income Tom Moberly, Will Stahl-Timmins. 365:doi 10.1136/bmj.l1489

The first of April is the day the Quality and Outcomes Framework (QOF) year starts. It is supposed to be the day each practice in England is ready to monitor the targets and objectives based on guidance from NICE and agreement with the BMA following yearly negotiations. And indeed each year several indicators are changed, and for 2019/20 there is no exception. Initial guidance was released at the end of January [1]. Unfortunately the QOF seem to be the usual bad joke as:

-There is inadequate support: NHS fails through their website ‘NHS employers’ [2] to show the current full set of indicators in time; clinical software in use in general practice neither shows the current indicators. General practitioners need to look for information not easily available to know what they are supposed to be doing today when reviewing their patients.

-There are inadequate indicators: Once again, despite clinical review, indicators of questionable clinical value remain [3]. For example, although indicator “RA002. The percentage of patients with rheumatoid arthritis, on the register, who have had a face-to-face review in the preceding 12 months” for a patient on methotrexate could be beneficial/acceptable [4] it can be argued there is no benefit for the many patients on no medication, some asymptomatic for years, some of whom already have a yearly check-up in secondary care, causing a waste of time to patients and clinicians.

-There are inadequate targets: The agreement between NHS England and GPC England “to replace the current blunt system of exception reporting with a more precise ‘personalised care adjustment’ “[2; page 21]. It is to be questioned if the retirement of indicator “DM007. The percentage of patients with diabetes on the register in whom the last IFCC- HbA1c is 59 mmol/mol or less in the preceding 12 months” with a range 35%-75% is properly substituted with the new indicator “DM020. The percentage of patients with diabetes without moderate or severe frailty on the register in whom the last IFCC-HbA1c is 58 mmol/mol or less in the preceding 12 months” and the same range. It implies simply all the patients with frailty that were perhaps removed before as “exception reporting” are no longer there, making the new target much harder to achieve. There has been no consideration on the impact of frailty on the tight management of diabetes. It seems the goal is to penalise GPs

These are just a few examples of current issues with the new QOFs in England. It is likely that primary care in other countries of the United Kingdom are laughing at the fact they already removed QOFs and the political game it has become.

References
1. Vautrey R, Dodge, I. (2019). Investment and evolution: A five-year framework for GP contract reform to implement The NHS Long Term Plan. Accessed on April 1st 2019 from https://www.england.nhs.uk/wp-content/uploads/2019/01/gp-contract-2019.pdf
2. NHS Employers. Quality and Outcomes Framework. Accessed on April 1st 2019 from https://www.nhsemployers.org/your-workforce/primary-care-contacts/genera...
3. Millares Martin, P. (2014). Quality and Outcomes Framework indicators should not be used without proper clinical evidence. BMJ, 348(Apr03 1). doi:10.1136/bmj.g2373
4. NICE Quality and Outcomes Framework indicator (2012). The percentage of patients with rheumatoid arthritis, on the register, who have had a face-to-face review in the preceding 12 months. NM58 indicator development feedback report. Accessed on April 1st 2019 from https://www.nice.org.uk/Media/Default/standards-and-indicators/qof%20ind...

Competing interests: As A GP partner my organisation receives QOF payments

05 April 2019
Pablo Millares Martin
GP
Whitehall Surgery
Leeds
Re: Clare Gerada: Mandatory training needs a fundamental review Clare Gerada. 365:doi 10.1136/bmj.l1406

The important issue of how training is delivered as well as its relevance are raised by Dr Gerada.

I would like to add two further points:

1. When reviewing my Mandatory and Statutory Training requirements recently I calculated that I need to devote at least 12 hours a year to this activity. Colleagues have said that this seems optimistic. Extrapolating this to the 400,000 consultants in the NHS in the UK and assuming that 40h contracts are the norm and are respected and we all take our leave, this means that 267 consultant work years per annum are “spent” on MAST training. This equates to one very large district general hospital doing nothing else all year. With such a large amount of time and hence money being spent we must examine how appropriate it is. I believe industry ensures their equivalent is done more efficiently.

2. At a time of flagging morale MAST training can add to irritation and upset.
Dr Gerada's example of sitting at home, alone with the computer considering the type of harrowing cases many of us have met and which have left a mark. Maybe they should have a "trigger warning"?
We have been trained to take in information and retain it. Repetition is difficult to tolerate when each year one is asked to do the same module in the same words.
Poor test design too can irritate - e.g. one could only get a given on-line certificate (which will remain unnamed here) once a certain score was achieved. There was at least one answer which had to be answered incorrectly in order to be marked "correct" and get one's certificate. I was pleased to note that I had learnt something as I correctly gave the incorrect answer three years in a row. Fortunately that test module has now changed.

Competing interests: No competing interests

05 April 2019
Bridget K MacDonald
Consultant Neurologist
Croydon University Hospital
Surrey
Re: David Oliver: The revolving door to the NHS lobby David Oliver. 365:doi 10.1136/bmj.l1297

I very much share David Oliver's concerns [1]. Additionally, I would point out Tom Jefferson's BMJ Opinion article of November 2017, 'The UK turns to Witty, Vallance, and Van Tam for leadership: revolving doors?' [2]. Jefferson states:

"Andrew Witty, who left the helm of GSK in April, is going to head up the UK government’s Accelerated Access Review (AAR) programme. The AAR is said to be aimed at helping NHS patients “get quicker access to innovative new diagnostic tools, treatments, and medical technologies.”

"Meanwhile Patrick Vallance is leaving his post of head of research and development at GSK as part of a re-shuffle by the new CEO Emma Walmsley. Vallance is taking up a senior position in the UK government, as Chief Scientific Adviser. His job will be “improving the quality and use of scientific evidence in government as head of the Government Office for Science.”

"Last but not least, another academic with extensive ties to industry over influenza and pandemic planning (and another ex-employee of GSK, Roche and Aventis Pasteur MSD), Jonathan Van Tam has been appointed Deputy Chief Medical Officer responsible for emergency preparedness and pandemic planning. This is a similarly senior position which holds great power and will potentially involve committing huge quantities of taxpayers’ money to projects preparing for future emergencies, which may or may not come about. It is also a very delicate role as the amount of lobbying and corporate pressure applied on governments before the 2009 influenza pandemic shows."

These events on their own look a bit like a pharmaceutical putsch.

[1 ]David Oliver: The revolving door to the NHS lobby
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1297 (Published 03 April 20

[2] Tom Jefferson: The UK turns to Witty, Vallance, and Van Tam for leadership: revolving doors?, 6 December 2017, https://blogs.bmj.com/bmj/2017/12/06/tom-jefferson-the-uk-turns-to-witty...

Competing interests: No competing interests

05 April 2019
John Stone
UK Editor
AgeofAutism.com
London N22

Pages